[Federal Register Volume 80, Number 182 (Monday, September 21, 2015)]
[Notices]
[Pages 56997-56999]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-23568]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-15-0009; Docket No. CDC-2015-0083]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing efforts to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies to take this opportunity to comment on proposed and/or 
continuing information collections, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
revision of the information collection entitled ``National Disease 
Surveillance Program--I--Case Reports.''

DATES: Written comments must be received on or before November 20, 
2015.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2015-
0083 by any of the following methods:
     Federal eRulemaking Portal: Regulation.gov. Follow the 
instructions for submitting comments.
     Mail: Leroy A. Richardson, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE., MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. All relevant comments received will be posted 
without change to Regulations.gov, including any personal information 
provided. For access to the docket to read background documents or 
comments received, go to Regulations.gov.
    Please note: All public comment should be submitted through the 
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the 
address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact the Information Collection Review Office, 
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information

[[Page 56998]]

collection before submitting the collection to OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; (d) ways to 
minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services 
to provide information. Burden means the total time, effort, or 
financial resources expended by persons to generate, maintain, retain, 
disclose or provide information to or for a Federal agency. This 
includes the time needed to review instructions; to develop, acquire, 
install and utilize technology and systems for the purpose of 
collecting, validating and verifying information, processing and 
maintaining information, and disclosing and providing information; to 
train personnel and to be able to respond to a collection of 
information, to search data sources, to complete and review the 
collection of information; and to transmit or otherwise disclose the 
information.

Proposed Project

    National Disease Surveillance Program I--Case Reports--(OMB Control 
Number 0920-0009, Expiration, 4/30/2016)--Revision--National Center for 
Emerging and Zoonotic Infectious Disease (NCEZID), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    Surveillance of the incidence and distribution of disease has been 
an important function of the US Public Health Service (PHS) since an 
1878 Act of Congress authorized the PHS to collect morbidity reports. 
After the Malaria Control in War Areas Program had fulfilled its 
original 1942 objective of reducing malaria transmission, its basic 
tenets were carried forward and broadened by the formation of the 
Communicable Disease Center (CDC) in 1946. CDC was conceived of as a 
well-equipped, broadly staffed agency used to translate facts about 
analysis of morbidity and mortality statistics on communicable diseases 
and through field investigations.
    The surveillance emphasis has shifted as certain diseases have 
declined in incidence, national emergencies have prompted involvement 
in new areas, and other diseases have taken on new aspects. 
Surveillance for the following diseases was approved three years ago: 
Creutzfeldt-Jakob Disease (CJD), Cyclosporiasis cayetanensis, Q Fever, 
Dengue, Reye Syndrome, Hantavirus pulmonary syndrome (HPS), Tick-borne 
Rickettsial Disease, Kawasaki syndrome, Trichinosis, Legionellosis, 
Tularemia, Lyme Disease (LD), Typhoid Fever, Malaria, Viral Hepatitis, 
and Plague. Due to change requests and surveillance systems moving to 
0920-0728 (National Notifiable Diseases Surveillance System (NNDSS)) 
during the last three years, the following diseases/conditions are now 
included in this program: Creutzfeldt-Jakob Disease (CJD), Reye 
Syndrome, Kawasaki syndrome, and Acute Flaccid Myelitis. CDC needs to 
continue this surveillance package for another 3 years to maintain 
continuity in these surveillance systems. The data throughout the years 
are used to monitor the occurrence of non-notifiable conditions and to 
plan and conduct prevention and control programs at the state, 
territorial, local and national levels.
    CDC currently collects data for certain diseases in summary form 
under OMB No. 0920-0004, (National Disease Surveillance Program II--
Disease Summaries). These disease summaries are for important, yet 
different types of infections from those covered in this disease case 
reports request. Maintaining separate OMB numbers for these two types 
of data collections assists CDC in managing the two surveillance 
activities.
    CDC works with state health departments to propose, coordinate, and 
evaluate nationwide surveillance systems. State epidemiologists are 
responsible for the collection, interpretation, and transmission of 
medical and epidemiological information to CDC.
    The original purpose for reporting communicable diseases was to 
determine the prevalence of diseases dangerous to public health. 
However, collecting data also provided the basis for planning and 
evaluating effective programs for prevention and control of infectious 
diseases. Current information on disease incidence is needed to study 
present and emerging disease problems. CDC coordination of nationwide 
reporting maintains uniformity so that comparisons can be made from 
state to state and year to year.
    In addition to development of prevention and control programs, 
surveillance data serves as statistical material for those engaged in 
research or medical practice, aid to health education officials and 
students, and data for manufacturers of pharmaceutical products. Annual 
surveillance data are published in the MMWR Surveillance Summary. The 
total burden requested is 190 hours, a decrease in 11,257 hours since 
the last submission. This is due to the other diseases moving to the 
Notifiable Diseases Surveillance System (0920-0728). There is no cost 
to respondents other than their time.

                                                            Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                             Number of      Avg. burden
              Type of respondents                               Form name                    Number of     responses per   per response    Total burden
                                                                                            respondents     respondent       (in hrs.)       (in hrs.)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Epidemiologist.................................  CJD....................................              20               2           20/60              13
Epidemiologist.................................  Kawasaki Syndrome......................              55               8           15/60             110
Epidemiologist.................................  Reye Syndrome..........................              50               1           20/60              17
Epidemiologist.................................  Acute Flaccid Myelitis.................             100               1           30/60              50
    Total......................................  .......................................  ..............  ..............  ..............             190
--------------------------------------------------------------------------------------------------------------------------------------------------------



[[Page 56999]]

Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-23568 Filed 9-18-15; 8:45 am]
 BILLING CODE 4163-18-P